Related Experiment Video
Updated: Jul 10, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
A Vaccine against Cancer: Can There Be a Possible Strategy to Face the Challenge? Possible Targets and Paradoxical
Roberto Zefferino1, Massimo Conese2
1Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
Abstract:
Is it possible to have an available vaccine that eradicates cancer? Starting from this question, this article tries to verify the state of the art, proposing a different approach to the issue. The variety of cancers and different and often unknown causes of cancer impede, except in some cited cases, the creation of a classical vaccine directed at the causative agent. The efforts of the scientific community are oriented toward stimulating the immune systems of patients, thereby preventing immune evasion, and heightening chemotherapeutic agents effects against cancer. However, the results are not decisive, because without any warning signs, metastasis often occurs. The purpose of this paper is to elaborate on a vaccine that must be administered to a patient in order to prevent metastasis; metastasis is an event that leads to death, and thus, preventing it could transform cancer into a chronic disease. We underline the fact that the field has not been studied in depth, and that the complexity of metastatic processes should not be underestimated. Then, with the aim of identifying the target of a cancer vaccine, we draw attention to the presence of the paradoxical actions of different mechanisms, pathways, molecules, and immune and non-immune cells characteristic of the tumor microenvironment at the primary site and pre-metastatic niche in order to exclude possible vaccine candidates that have opposite effects/behaviors; after a meticulous evaluation, we propose possible targets to develop a metastasis-targeting vaccine. We conclude that a change in the current concept of a cancer vaccine is needed, and the efforts of the scientific community should be redirected toward a metastasis-targeting vaccine, with the increasing hope of eradicating cancer.
Insights
Developing a cancer vaccine to prevent metastasis could transform cancer into a manageable chronic disease. This approach targets the spread of cancer, offering new hope for eradication.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Traditional cancer vaccines face challenges due to cancer's diversity and unknown causes.
- Current research focuses on immune system stimulation and enhancing chemotherapy, but metastasis remains a critical issue.
- Metastasis is the primary cause of cancer-related death, highlighting the need for targeted prevention strategies.
Purpose of the Study:
- To propose a novel vaccine strategy focused on preventing cancer metastasis.
- To explore the potential of transforming cancer into a chronic, manageable disease by inhibiting metastasis.
- To identify viable targets for a metastasis-targeting cancer vaccine.
Main Methods:
- Reviewing the current state of cancer vaccine research and its limitations.
- Analyzing the complex mechanisms, pathways, and cellular components of the tumor microenvironment and pre-metastatic niche.
- Evaluating paradoxical actions of various factors within the tumor microenvironment to identify suitable vaccine targets.
Main Results:
- The complexity of metastatic processes and the tumor microenvironment presents significant challenges.
- Paradoxical actions of key molecules and cells within the tumor microenvironment require careful consideration for vaccine development.
- Specific targets for a metastasis-targeting vaccine have been identified through meticulous evaluation.
Conclusions:
- A paradigm shift in cancer vaccine development is necessary, moving beyond traditional approaches.
- Focusing on metastasis prevention offers a more promising strategy for improving patient outcomes and potentially eradicating cancer.
- Redirecting scientific efforts toward metastasis-targeting vaccines could significantly increase hope for cancer eradication.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers

